IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0221747.html
   My bibliography  Save this article

Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis

Author

Listed:
  • Jaime Gonzalez Cardona
  • Matthew D Smith
  • Jingya Wang
  • Leslie Kirby
  • Jason T Schott
  • Todd Davidson
  • Jodi L Karnell
  • Katharine A Whartenby
  • Peter A Calabresi

Abstract

Multiple sclerosis (MS) is characterized by demyelinated lesions in the central nervous system. Destruction of myelin and secondary damage to axons and neurons leads to significant disability, particularly in people with progressive MS. Accumulating evidence suggests that the potential for myelin repair exists in MS, although for unclear reasons this process fails. The cells responsible for producing myelin, the oligodendrocytes, and their progenitors, oligodendrocyte precursor cells (OPCs), have been identified at the site of lesions, even in adults. Their presence suggests the possibility that endogenous remyelination without transplantation of donor stem cells may be a mechanism for myelin repair in MS. Strategies to develop novel therapies have focused on induction of signaling pathways that stimulate OPCs to mature into myelin-producing oligodendrocytes that could then possibly remyelinate lesions. We have been investigating pharmacological approaches to enhance OPC differentiation, and have identified that the combination of two agents, triiodothyronine (T3) and quetiapine, leads to an additive effect on OPC differentiation and consequent myelin production via both overlapping and distinct signaling pathways. While the ultimate production of myelin requires cholesterol biosynthesis, we identified that quetiapine enhances gene expression in this pathway more potently than T3. Two blockers of cholesterol production, betulin and simvastatin, reduced OPC differentiation into myelin producing oligodendrocytes. Elucidating the nature of agents that lead to complementary and additive effects on oligodendrocyte differentiation and myelin production may pave the way for more efficient induction of remyelination in people with MS.

Suggested Citation

  • Jaime Gonzalez Cardona & Matthew D Smith & Jingya Wang & Leslie Kirby & Jason T Schott & Todd Davidson & Jodi L Karnell & Katharine A Whartenby & Peter A Calabresi, 2019. "Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-19, September.
  • Handle: RePEc:plo:pone00:0221747
    DOI: 10.1371/journal.pone.0221747
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0221747
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0221747&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0221747?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Friedemann Paul & Sonia Waiczies & Jens Wuerfel & Judith Bellmann-Strobl & Jan Dörr & Helmar Waiczies & Mareile Haertle & Klaus D Wernecke & Hans-Dieter Volk & Orhan Aktas & Frauke Zipp, 2008. "Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis," PLOS ONE, Public Library of Science, vol. 3(4), pages 1-9, April.
    2. Vishal A. Deshmukh & Virginie Tardif & Costas A. Lyssiotis & Chelsea C. Green & Bilal Kerman & Hyung Joon Kim & Krishnan Padmanabhan & Jonathan G. Swoboda & Insha Ahmad & Toru Kondo & Fred H. Gage & A, 2013. "A regenerative approach to the treatment of multiple sclerosis," Nature, Nature, vol. 502(7471), pages 327-332, October.
    3. Sawsan Youssef & Olaf Stüve & Juan C. Patarroyo & Pedro J. Ruiz & Jennifer L. Radosevich & Eun Mi Hur & Manuel Bravo & Dennis J. Mitchell & Raymond A. Sobel & Lawrence Steinman & Scott S. Zamvil, 2002. "The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease," Nature, Nature, vol. 420(6911), pages 78-84, November.
    4. Fadi J. Najm & Mayur Madhavan & Anita Zaremba & Elizabeth Shick & Robert T. Karl & Daniel C. Factor & Tyler E. Miller & Zachary S. Nevin & Christopher Kantor & Alex Sargent & Kevin L. Quick & Daniela , 2015. "Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo," Nature, Nature, vol. 522(7555), pages 216-220, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Giampiero Porcu & Eliseo Serone & Velia De Nardis & Daniele Di Giandomenico & Giuseppe Lucisano & Marco Scardapane & Anna Poma & Antonella Ragnini-Wilson, 2015. "Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-22, December.
    2. Nick Bansback & Roberta Ara & Sue Ward & Aslam Anis & Hyon Choi, 2009. "Statin Therapy in Rheumatoid Arthritis," PharmacoEconomics, Springer, vol. 27(1), pages 25-37, January.
    3. Chien-Cheng Chien & Po-Huang Chen & Chi-Hsiang Chung & Chien-An Sun & Wu-Chien Chien & Ke-Hung Chien, 2021. "Association between Statins and Retinal Vascular Occlusion: A Population-Based Cohort Study," IJERPH, MDPI, vol. 18(18), pages 1-11, September.
    4. Friedemann Paul & Sonia Waiczies & Jens Wuerfel & Judith Bellmann-Strobl & Jan Dörr & Helmar Waiczies & Mareile Haertle & Klaus D Wernecke & Hans-Dieter Volk & Orhan Aktas & Frauke Zipp, 2008. "Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis," PLOS ONE, Public Library of Science, vol. 3(4), pages 1-9, April.
    5. Sophie Martin & Kevin C. Allan & Otis Pinkard & Thomas Sweet & Paul J. Tesar & Jeff Coller, 2022. "Oligodendrocyte differentiation alters tRNA modifications and codon optimality-mediated mRNA decay," Nature Communications, Nature, vol. 13(1), pages 1-21, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0221747. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.